US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist

3.620
-0.130-3.47%

Close Oct 16 16:00 ET

3.03MMarket Cap0.00P/E (TTM)

Scinai Immunotherapeutics Stock Forum

MARKET-TEST-DUMMY

Sep 28 13:33

👁

$Scinai Immunotherapeutics (SCNI.US)$

FattyChick

Sep 12 07:10

$Scinai Immunotherapeutics (SCNI.US)$ Still on low float

Trytosaveabit

Aug 29 05:40

Update

$Scinai Immunotherapeutics (SCNI.US)$ Scinai Regains Full Compliance with Nasdaq Listing Requirements
9 MINUTES AGO, 6:31 AM EDT
VIA PR NEWSWIRE

Stock Region

Jul 15 17:34

Biotechnology Company Announces Successful Preclinical Study Results For Psoriasis Treatment

Promising In-Vivo Results for Scinai Immunotherapeutics' Psoriatic Human Skin Model.
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biotechnology company known for its focus on developing inflammation and immunology (I&I) biological products, has announced successful in-vivo preclinical study results. The results pertain to its innovative anti IL-17A/F VHH antibody fragment, known as 'NanoAb', which fun...